A detailed history of Beutel, Goodman & CO Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beutel, Goodman & CO Ltd. holds 3,446,817 shares of MRK stock, worth $338 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares
3,446,817
Previous 2,463,939 39.89%
Holding current value
$338 Million
Previous $305 Million 28.32%
% of portfolio
1.93%
Previous 1.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $109 Million - $127 Million
982,878 Added 39.89%
3,446,817 $391 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $3.97 Million - $4.27 Million
32,099 Added 1.32%
2,463,939 $305 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $139,058 - $162,034
1,228 Added 0.05%
2,431,840 $321 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $169,304 - $184,243
-1,690 Reduced 0.07%
2,430,612 $265 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $20.7 Million - $23 Million
200,856 Added 9.0%
2,432,302 $250 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $19.1 Million - $20.8 Million
176,009 Added 8.56%
2,231,446 $257 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $5.25 Million - $5.86 Million
51,000 Added 2.54%
2,055,437 $219 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $116 Million - $149 Million
-1,326,189 Reduced 39.82%
2,004,437 $222 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $48.3 Million - $54.3 Million
-571,603 Reduced 14.65%
3,330,626 $287 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $45.8 Million - $51.9 Million
-548,197 Reduced 12.32%
3,902,229 $356 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $9.18 Million - $10.3 Million
124,900 Added 2.89%
4,450,426 $365 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $2.26 Million - $2.83 Million
31,225 Added 0.73%
4,325,526 $332 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $13.2 Million - $14.5 Million
184,220 Added 4.48%
4,294,301 $323 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $53 Million - $58.6 Million
753,653 Added 22.45%
4,110,081 $320 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $91.1 Million - $107 Million
1,323,498 Added 65.1%
3,356,428 $259 Million
Q4 2020

Feb 05, 2021

BUY
$71.77 - $79.65 $8.76 Million - $9.72 Million
122,082 Added 6.39%
2,032,930 $166 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $26.2 Million - $29.7 Million
358,118 Added 23.06%
1,910,848 $159 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $62 Million - $70.6 Million
880,884 Added 131.11%
1,552,730 $120 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $20.5 Million - $28.4 Million
322,853 Added 92.51%
671,846 $51.7 Million
Q4 2019

Feb 24, 2020

SELL
$77.58 - $87.54 $4.51 Million - $5.09 Million
-58,095 Reduced 14.27%
348,993 $31.7 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $9.74 Million - $11 Million
-125,591 Reduced 23.58%
407,088 $37 Million
Q3 2019

Oct 31, 2019

SELL
$76.08 - $82.93 $1.6 Million - $1.75 Million
-21,074 Reduced 3.81%
532,679 $748,000
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $131,089 - $153,144
1,877 Added 0.34%
553,753 $0
Q1 2019

Apr 26, 2019

BUY
$69.58 - $79.36 $630,951 - $719,636
9,068 Added 1.67%
551,876 $34.3 Million
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $93,423 - $108,416
1,432 Added 0.26%
542,808 $3.04 Million
Q3 2018

Oct 31, 2018

SELL
$57.69 - $67.84 $15.9 Million - $18.7 Million
-275,021 Reduced 33.69%
541,376 $29.7 Million
Q2 2018

Jul 30, 2018

SELL
$50.83 - $59.72 $4.74 Million - $5.56 Million
-93,156 Reduced 10.24%
816,397 $37.7 Million
Q1 2018

Apr 30, 2018

SELL
$50.96 - $59.23 $1.39 Million - $1.61 Million
-27,189 Reduced 2.9%
909,553 $39.4 Million
Q4 2017

Feb 21, 2018

BUY
$51.62 - $61.64 $48.4 Million - $57.7 Million
936,742
936,742 $42.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Beutel, Goodman & CO Ltd. Portfolio

Follow Beutel, Goodman & CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beutel, Goodman & CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Beutel, Goodman & CO Ltd. with notifications on news.